THERACRYF PLC
Get an alert when THERACRYF PLC files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1.5m
-62.5% lowest in 3 filed years
Net assets
£2.7m
-54.5% vs 2025
Employees
9
0% vs 2025
Profit before tax
-£3.6m
-71.1% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
Consequently, the requirement for future funding represents a material uncertainty that may cast significant doubt on the Group's ability to continue as a going concern and, therefore, that it may be unable to realise its assets and discharge its liabilities in the normal course of business.
-
Going-concern uncertainty disclosed
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 | 2026-03-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £396,000 | £0 | — | — | |
| Operating profit | -£3,566,000 | -£2,124,000 | -£3,695,000 | -74% | |
| Profit before tax | -£3,566,000 | -£2,085,000 | -£3,568,000 | -71.1% | |
| Net profit | -£3,137,000 | -£1,941,000 | -£3,531,000 | -81.9% | |
| Cash | £2,004,000 | £4,114,000 | £1,543,000 | -62.5% | |
| Total assets less current liabilities | £2,340,000 | £6,366,000 | £3,128,000 | -50.9% | |
| Net assets | £2,341,000 | £5,969,000 | £2,717,000 | -54.5% | |
| Equity | £2,341,000 | £5,969,000 | £2,717,000 | -54.5% | |
| Average employees | 9 | 9 | 9 | 0% | |
| Wages | £755,000 | £563,000 | £840,000 | +49.2% | |
| Directors' remuneration | £539,000 | £422,000 | £510,000 | +20.9% | |
| Directors' pension contributions | £22,000 | £22,000 | £22,000 | 0% | |
| Highest paid director | £302,890 | £204,191 | £223,479 | +9.4% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|
| Return on capital employed | -152.4% | -33.4% | -118.1% | |
| Gearing (liabilities / total assets) | 23.5% | 21.8% | 43.6% | |
| Current ratio | 4.19x | 4.09x | 1.36x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- THERACRYF PLC 2024-04-25 → present
- EVGEN PHARMA PLC 2015-10-14 → 2024-04-25
- EVGEN PHARMA LIMITED 2014-10-02 → 2015-10-14
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“Consequently, the requirement for future funding represents a material uncertainty that may cast significant doubt on the Group's ability to continue as a going concern and, therefore, that it may be unable to realise its assets and discharge its liabilities in the normal course of business.”
Group structure
- THERACRYF PLC · parent
- TheraCryf Pharma Ltd 100%
- Chronos Therapeutics Ltd 100%
Significant events
- “On 05 April 2024, the Group acquired the entire share capital of Chronos Therapeutics Limited for a total combined consideration of £1,983k.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| PRISM COSEC LIMITED | Corporate Secretary | 2018-08-20 | — | — |
| BARGE, Alan John, Dr | Director | 2015-10-21 | Sep 1957 | British |
| HAENNINEN, Toni Markus Antero | Director | 2024-01-01 | Dec 1977 | Finnish |
| JONES, Huw, Dr | Director | 2020-10-01 | Nov 1959 | British |
| SMITH, David Alastair Maclaughlin, Dr | Director | 2025-02-19 | Oct 1966 | British |
| WARDLE, Edward James Norman | Director | 2025-05-01 | May 1991 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DAVID VENUS & COMPANY LLP | Corporate Secretary | 2015-06-29 | 2018-08-20 |
| BRADSHAW, John | Director | 2014-11-21 | 2017-03-01 |
| CLARE, Barry | Director | 2014-10-02 | 2023-09-22 |
| CLEMENT-DAVIES, Susan Elizabeth | Director | 2018-11-08 | 2023-12-31 |
| D'ABBADIE, Marc Francois | Director | 2014-11-21 | 2018-11-08 |
| FODEN, Susan Elizabeth, Dr | Director | 2014-11-21 | 2024-11-01 |
| FRANKLIN, Stephen, Dr | Director | 2014-10-02 | 2020-04-30 |
| JONES, Huw, Dr | Director | 2020-10-30 | 2020-10-30 |
| MOULSON, Richard Anthony | Director | 2017-03-01 | 2023-07-20 |
| WYATT, Mark | Director | 2014-11-21 | 2017-03-31 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 109 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-09-28 RESOLUTIONS Resolution
- 2026-09-28 MA Memorandum articles
- 2025-08-14 RESOLUTIONS Resolution
- 2024-07-25 RESOLUTIONS Resolution
- 2024-04-25 CERTNM Certificate change of name company PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-10-14 | AA | accounts | Accounts with accounts type group | |
| 2026-09-28 | RESOLUTIONS | resolution | Resolution | |
| 2026-09-28 | MA | incorporation | Memorandum articles | |
| 2025-10-21 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-08-29 | AA | accounts | Accounts with accounts type group | |
| 2025-08-14 | RESOLUTIONS | resolution | Resolution | |
| 2025-05-07 | SH01 | capital | Capital allotment shares | |
| 2025-05-07 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-16 | SH01 | capital | Capital allotment shares | |
| 2025-03-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-12-15 | SH01 | capital | Capital allotment shares | |
| 2024-11-06 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-31 | CH01 | officers | Change person director company with change date | |
| 2024-10-31 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-29 | SH01 | capital | Capital allotment shares | |
| 2024-10-29 | CH01 | officers | Change person director company with change date | |
| 2024-07-25 | RESOLUTIONS | resolution | Resolution | |
| 2024-07-15 | AA | accounts | Accounts with accounts type group | |
| 2024-04-25 | CERTNM | change-of-name | Certificate change of name company | |
| 2024-01-01 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 3
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Spotted an error, or named here and want to reply? Report it · How we handle corrections